Microbial biomolecule-driven identification of next-gen GSK-3β inhibitors for brain disorders. - Lamia Islam; Hriddhi Sarker; Md Al Amin; Rahnuma Tabassum; Arpita Nandi; Tarikul Islam; Md Azad Patwary; Fairooz Ibnat; Firoz Ahmed; Noimul Hasan Siddiquee (Comput. Biol. Chem., 2026)

Microbial metabolites as promising alternatives to empagliflozin for type 2 diabetes management. - Amzadur Rahman Rakib; Tahmina Akter Bristi; Jannatul Shifa; Sabikunnahar Surovi; Mrittika Banik; Anika Bushra; Tasmia Sultana; Shanjida Akter Joyoti; Md. Toslim Mahmud; Firoz Ahmed; Noimul Hasan Siddiquee (Netw. Model. Anal. Health Informatics Bioinform., 2026)